Verition Fund Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.05M | Buy |
48,095
+30,099
| +167% | +$3.78M | 0.03% | 742 |
|
|
2025
Q1 | $1.99M | Buy |
17,996
+7,301
| +68% | +$807K | 0.01% | 1220 |
|
|
2024
Q4 | $1.46M | Buy |
10,695
+2,370
| +28% | +$324K | 0.01% | 1329 |
|
|
2024
Q3 | $959K | Buy |
+8,325
| New | +$959K | ﹤0.01% | 1347 |
|
|
2024
Q2 | – | Sell |
-4,202
| Closed | -$580K | – | 2484 |
|
|
2024
Q1 | $580K | Buy |
4,202
+2,305
| +122% | +$318K | ﹤0.01% | 1407 |
|
|
2023
Q4 | $250K | Sell |
1,897
-38,782
| -95% | -$5.11M | ﹤0.01% | 1467 |
|
|
2023
Q3 | $4.58M | Sell |
40,679
-3,773
| -8% | -$424K | 0.05% | 426 |
|
|
2023
Q2 | $4.19M | Sell |
44,452
-25,110
| -36% | -$2.37M | 0.06% | 371 |
|
|
2023
Q1 | $7.04M | Buy |
69,562
+64,796
| +1,360% | +$6.56M | 0.1% | 243 |
|
|
2022
Q4 | $569K | Buy |
4,766
+1,922
| +68% | +$230K | 0.01% | 963 |
|
|
2022
Q3 | $302K | Sell |
2,844
-946
| -25% | -$100K | ﹤0.01% | 1723 |
|
|
2022
Q2 | $369K | Sell |
3,790
-99,744
| -96% | -$9.71M | 0.01% | 1557 |
|
|
2022
Q1 | $9.71M | Buy |
+103,534
| New | +$9.71M | 0.12% | 117 |
|
|
2021
Q3 | – | Sell |
-42,738
| Closed | -$4.16M | – | 1916 |
|
|
2021
Q2 | $4.16M | Buy |
42,738
+36,323
| +566% | +$3.53M | 0.04% | 215 |
|
|
2021
Q1 | $624K | Sell |
6,415
-97,953
| -94% | -$9.53M | 0.01% | 662 |
|
|
2020
Q4 | $10M | Buy |
104,368
+99,223
| +1,929% | +$9.51M | 0.09% | 79 |
|
|
2020
Q3 | $495K | Buy |
5,145
+2,543
| +98% | +$245K | 0.01% | 505 |
|
|
2020
Q2 | $317K | Buy |
+2,602
| New | +$317K | 0.01% | 711 |
|
|
2020
Q1 | – | Sell |
-15,216
| Closed | -$1.64M | – | 797 |
|
|
2019
Q4 | $1.64M | Buy |
15,216
+12,202
| +405% | +$1.31M | 0.03% | 241 |
|
|
2019
Q3 | $272K | Buy |
+3,014
| New | +$272K | 0.01% | 716 |
|
|
2019
Q2 | – | Sell |
-3,844
| Closed | -$339K | – | 1152 |
|
|
2019
Q1 | $339K | Buy |
+3,844
| New | +$339K | 0.01% | 725 |
|
|
2018
Q4 | – | Sell |
-28,801
| Closed | -$3.54M | – | 1023 |
|
|
2018
Q3 | $3.54M | Buy |
+28,801
| New | +$3.54M | 0.13% | 137 |
|
|
2018
Q2 | – | Sell |
-4,337
| Closed | -$360K | – | 1162 |
|
|
2018
Q1 | $360K | Sell |
4,337
-4,024
| -48% | -$334K | 0.03% | 700 |
|
|
2017
Q4 | $649K | Buy |
+8,361
| New | +$649K | 0.06% | 356 |
|